Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00641394 · ClinicalTrials.gov registry record · NA

The Effect of Psychotherapy on Stress Biochemistry: An RCT of Psychotherapy and Emotional Freedom Techniques (EFT)

A NA study of Depression and Anxiety, sponsored by Soul Medicine Institute.

Completed
Registry status
NA
Development phase
83
Enrollment target
1
Study location

NCT00641394: Completed NA study of Depression and Anxiety, sponsored by Soul Medicine Institute.

NCT00641394 is a NA study of Depression and Anxiety that has completed, run by Soul Medicine Institute. The registered enrollment target is 83 participants, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00641394, a NA study of Depression and Anxiety, has completed, sponsored by Soul Medicine Institute.

COMPLETED
Registry status
NA
Development phase
83 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to determine whether there is a change in levels of cortisol, a key stress hormone, during the course of a psychotherapy session. The two forms of psychotherapy compared are Cognitive Behavioral Therapy (CBT) and Emotional Freedom Techniques (EFT). A no treatment control group provides a baseline measure. The change in cortisol level is compared between the start and end of a one hour session.

Interventions

  • BEHAVIORAL Cognitive Behavioral Therapy (CBT)
  • BEHAVIORAL Psychotherapy: Emotional Freedom Techniques (EFT)

Study Locations (1)

California

  • Soul Medicine Institute - Santa Rosa

Trial Details

FieldValue
Enrollment Target 83 participants
Start Date 2008-04
Est. Completion 2010-09
Phase NA
Soul Medicine Institute

8 total trials

What the finished NCT00641394 record still lists

NCT00641394 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 83 participants, a relatively small participant target, below the 786-participant average among 679 other Depression trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Depression appearing as the primary indexed condition, and to 2 interventions - of which Cognitive Behavioral Therapy (CBT) is the first listed.

NCT00641394 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT00641394 about?

NCT00641394 is a clinical study titled "The Effect of Psychotherapy on Stress Biochemistry: An RCT of Psychotherapy and Emotional Freedom Techniques (EFT)". The purpose of this study is to determine whether there is a change in levels of cortisol, a key stress hormone, during the course of a psychotherapy session. The two forms of psychotherapy compared are Cognitive Behavioral Therapy (CBT) and Emotional Freedom Techniques (EFT). A no treatment control...

What is the current status of trial NCT00641394?

This trial is currently completed. It is a NA study. The enrollment target is 83 participants. The study started on 2008-04. Estimated completion is 2010-09.

What conditions does trial NCT00641394 study?

This clinical trial studies the following conditions: Depression, Anxiety, Stress.

What interventions are being tested in trial NCT00641394?

The interventions under investigation include: Cognitive Behavioral Therapy (CBT) (BEHAVIORAL), Psychotherapy: Emotional Freedom Techniques (EFT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT00641394?

This trial is sponsored by Soul Medicine Institute, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00641394 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00641394's enrollment target sits among peer trials

83 369th of 679 higher than 311 of 679 other Depression trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02974647 · 83 participants · Phase 2

    Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • NCT03919292 · 83 participants · Phase 1

    Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

  • NCT04626674 · 83 participants · Phase 1

    A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD)

  • NCT05277168 · 83 participants · Phase 1

    A Trial TO Evaluate THE Safety, Tolerability, Pharmacokinetics, AND Efficacy OF Shr-a1904 IN Subjects With Advanced Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00641394, the US trial registry maintained by the National Library of Medicine. NCT00641394 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.